LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | AZD8330 | 0.37 | uM | LJP5 | 72 | hr | 658 | 989 | 3933 | 0.2515 | 0.1710 |
Hs 578T | AZD8330 | 1.11 | uM | LJP5 | 72 | hr | 658 | 1003 | 3933 | 0.2550 | 0.1771 |
Hs 578T | AZD8330 | 3.33 | uM | LJP5 | 72 | hr | 658 | 1057 | 3933 | 0.2688 | 0.2016 |
Hs 578T | AZD8330 | 10 | uM | LJP5 | 72 | hr | 658 | 1027 | 3933 | 0.2612 | 0.1884 |
Hs 578T | TGX221 | 0.04 | uM | LJP5 | 72 | hr | 658 | 3589 | 3933 | 0.9125 | 0.9303 |
Hs 578T | TGX221 | 0.12 | uM | LJP5 | 72 | hr | 658 | 3595 | 3933 | 0.9140 | 0.9314 |
Hs 578T | TGX221 | 0.37 | uM | LJP5 | 72 | hr | 658 | 3599 | 3933 | 0.9150 | 0.9323 |
Hs 578T | TGX221 | 1.11 | uM | LJP5 | 72 | hr | 658 | 3518 | 3933 | 0.8943 | 0.9149 |
Hs 578T | TGX221 | 3.33 | uM | LJP5 | 72 | hr | 658 | 3510 | 3933 | 0.8925 | 0.9135 |
Hs 578T | TGX221 | 10 | uM | LJP5 | 72 | hr | 658 | 2967 | 3933 | 0.7543 | 0.7929 |
Hs 578T | GSK1059615 | 0.04 | uM | LJP5 | 72 | hr | 658 | 3932 | 3933 | 0.9998 | 0.9997 |
Hs 578T | GSK1059615 | 0.04 | uM | LJP6 | 72 | hr | 658 | 3425 | 3761 | 0.9107 | 0.9266 |
Hs 578T | GSK1059615 | 0.12 | uM | LJP5 | 72 | hr | 658 | 3367 | 3933 | 0.8561 | 0.8825 |
Hs 578T | GSK1059615 | 0.12 | uM | LJP6 | 72 | hr | 658 | 3115 | 3761 | 0.8285 | 0.8558 |
Hs 578T | GSK1059615 | 0.37 | uM | LJP5 | 72 | hr | 658 | 2717 | 3933 | 0.6908 | 0.7326 |
Hs 578T | GSK1059615 | 0.37 | uM | LJP6 | 72 | hr | 658 | 2752 | 3761 | 0.7318 | 0.7664 |
Hs 578T | GSK1059615 | 1.11 | uM | LJP5 | 72 | hr | 658 | 1523 | 3933 | 0.3873 | 0.3842 |
Hs 578T | GSK1059615 | 1.11 | uM | LJP6 | 72 | hr | 658 | 1663 | 3761 | 0.4422 | 0.4453 |
Hs 578T | GSK1059615 | 3.33 | uM | LJP5 | 72 | hr | 658 | 741 | 3933 | 0.1883 | 0.0464 |
Hs 578T | GSK1059615 | 3.33 | uM | LJP6 | 72 | hr | 658 | 860 | 3761 | 0.2287 | 0.1121 |
Hs 578T | GSK1059615 | 10 | uM | LJP5 | 72 | hr | 658 | 223 | 3933 | 0.0568 | -0.3427 |
Hs 578T | GSK1059615 | 10 | uM | LJP6 | 72 | hr | 658 | 479 | 3761 | 0.1276 | -0.1210 |
Hs 578T | Brivanib | 0.04 | uM | LJP5 | 72 | hr | 658 | 3799 | 3933 | 0.9658 | 0.9731 |
Hs 578T | Brivanib | 0.12 | uM | LJP5 | 72 | hr | 658 | 3625 | 3933 | 0.9218 | 0.9377 |
Hs 578T | Brivanib | 0.37 | uM | LJP5 | 72 | hr | 658 | 3736 | 3933 | 0.9500 | 0.9602 |